Synergistic inhibition of mesothelioma cell growth by the combination of clofarabine and resveratrol involves Nrf2 downregulation
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
We previously reported that MSTO-211H cells have a higher capacity to regulate Nrf2 activation in response to changes in the cellular redox environment. To further characterize its biological significance, the response of Nrf2, a transcription factor that regulates ARE-containing genes, on the synergistic cytotoxic effect of clofarabine and resveratrol was investigated in mesothelioma cells. The combination treatment showed a marked growth-inhibitory effect, which was accompanied by suppression of Nrf2 activation and decreased expression of heme oxygenase-1 (HO-1). While transient overexpression of Nrf2 conferred protection against the cytotoxicity caused by their combination, knockdown of Nrf2 expression using siRNA enhanced their cytotoxic effect. Pretreatment with Ly294002, a PI3K inhibitor, augmented the decrease in HO-1 level by their combination, whereas no obvious changes were observed in Nrf2 levels. Altogether, these results suggest that the synergistic cytotoxic effect of clofarabine and resveratrol was mediated, at least in part, through suppression of Nrf2 signaling. [BMB Reports 2012; 45(11): 647-652]
Abstract
We previously reported that MSTO-211H cells have a higher capacity to regulate Nrf2 activation in response to changes in the cellular redox environment. To further characterize its biological significance, the response of Nrf2, a transcription factor that regulates ARE-containing genes, on the synergistic cytotoxic effect of clofarabine and resveratrol was investigated in mesothelioma cells. The combination treatment showed a marked growth-inhibitory effect, which was accompanied by suppression of Nrf2 activation and decreased expression of heme oxygenase-1 (HO-1). While transient overexpression of Nrf2 conferred protection against the cytotoxicity caused by their combination, knockdown of Nrf2 expression using siRNA enhanced their cytotoxic effect. Pretreatment with Ly294002, a PI3K inhibitor, augmented the decrease in HO-1 level by their combination, whereas no obvious changes were observed in Nrf2 levels. Altogether, these results suggest that the synergistic cytotoxic effect of clofarabine and resveratrol was mediated, at least in part, through suppression of Nrf2 signaling. [BMB Reports 2012; 45(11): 647-652]
참고문헌 (21)
- Belli, C., "Malignant pleural mesothelioma: current treatments and emerging drugs", Expert. Opin. Emerg. Drugs, 14, pp.423~437 (2009)
- Kim, K. U., "A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance", Am. J. Respir. Cell Mol. Biol., 33, pp.541~548 (2005)
- Kensler, T. W., "Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway", Annu. Rev. Pharmacol. Toxicol., 47, pp.89~116 (2007)
- Zhang, D. D., "Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress", Mol. Cell. Biol., 23, pp.8137~8151 (2003)
- Jiang, T., "High levels of Nrf2 determine chemoresistance in type II endometrial cancer", Cancer Res., 70, pp.5486~5496 (2010)
- Zhang, P., "Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth", Mol. Cancer Ther., 9, pp.336~346 (2010)
- Kim, S. K., "Increased expression of Nrf2", ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells, 2008, pp.45, 537~546[DOI]
- Lee, Y. J., "Reactive oxygen species and PI3K", Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells, 2012, pp.50(2), 116~123[DOI]
- Shakibaei, M., "Resveratrol addiction: to die or not to die", Mol.Nutr. Food Res., 53, pp.115~128 (2009)
- Homma, S., "Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer", Clin. Cancer Res., 15, pp.3423~3432 (2009)
- Shibata, T., "NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer", Neoplasia, 13, pp.864~873 (2011)
- Santandreu, F. M., "Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells", Cell Physiol. Biochem., 28, pp.219~228 (2011)
- Quan, F., "Reversal effect of resveratrol on multidrug resistance in KBv200 cell line", Biomed. Pharmacother., 62, pp.622~629 (2008)
- Berberat, P. O., "Inhibition of heme oxygenase- 1 increases responsiveness of pancreatic cancer cells to anticancer treatment", Clin. Cancer Res., 11, pp.3790~3798 (2005)
- Frampton, G. A., "Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents", Lab. Invest., 90, pp.1325~1338 (2010)
- Suzuki, Y., "Activation of the PI3KAKT pathway in human malignant mesothelioma cells", Mol. Med. Rep., 2, pp.181~188 (2009)
- Tajima, K., "Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells", Oncogene, 29, pp.1941~1951 (2010)
- Martin, D., "Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3 kinase", Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical, carnosol, 2004, pp.279, 8919~8929
- Reisman, S. A., "Oleanolic acid activates Nrf2 and protects fromacetaminophen hepatotoxicity via Nrf2-dependent andNrf2-independent processes", Biochem. Pharmacol., 77, pp.1273~1282 (2009)
- Ramanathan, B., "Resistance to paclitaxel is proportional to cellular total antioxidant capacity", Cancer Res., 65, pp.8455~8460 (2005)
- Kinnula, V. L., "Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung", FEBS Lett., 569, pp.1~6 (2004)